APA (7th ed.) Citation

Nakajo, M., Kitajima, K., Kaida, H., Morita, T., Minamimoto, R., Ishibashi, M., & Yoshiura, T. (2020). The clinical value of PERCIST to predict tumour response and prognosis of patients with oesophageal cancer treated by neoadjuvant chemoradiotherapy. Clinical Radiology, 75(1), 79.e9. https://doi.org/10.1016/j.crad.2019.09.132

Chicago Style (17th ed.) Citation

Nakajo, M., K. Kitajima, H. Kaida, T. Morita, R. Minamimoto, M. Ishibashi, and T. Yoshiura. "The Clinical Value of PERCIST to Predict Tumour Response and Prognosis of Patients with Oesophageal Cancer Treated by Neoadjuvant Chemoradiotherapy." Clinical Radiology 75, no. 1 (2020): 79.e9. https://doi.org/10.1016/j.crad.2019.09.132.

MLA (9th ed.) Citation

Nakajo, M., et al. "The Clinical Value of PERCIST to Predict Tumour Response and Prognosis of Patients with Oesophageal Cancer Treated by Neoadjuvant Chemoradiotherapy." Clinical Radiology, vol. 75, no. 1, 2020, p. 79.e9, https://doi.org/10.1016/j.crad.2019.09.132.